Aggressive Natural Killer Cell Leukemia/Lymphoma: Case Report, use of Telesynergy™ and Review of the Literature

Reference

• Lanier, L.L., Phillips, J.H., Hackett, J., Jr., Tutt, M. and Kumar, V. (1986) "Natural killer cells: definition of a cell type rather than a function", Journal of Immunology, 137, 2735–2739.
   Google Scholar
• Spits, H., Lanier, L.L. and Phillips, J.H. (1995) "Development of human T and natural killer cells", Blood, 85, 2654–2670.
   Google Scholar
• Lanier, L.L., Chang, C., Azuma, M., Ruitenberg, ii., Hemperly, J.J. and Phillips, J.H. (1991) "Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56)", Journal of Immunology, 146, 4421–4426.
   PubMed Web of Science ®Google Scholar
• Jaffe, ES., Chan, J.K., Su, Ii., Frizzera, G., Mori, S., Feller, AC., et al. (1996) "Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Defini-tions, differential diagnosis, and epidemiology", American Journal of Surgery and Pathology, 20, 103–111.
   Google Scholar
• Jaffe, E.S. (1996) "Classification of natural killer (NK) cell and NK-like T-cell malignancies", Blood, 87, 1207–1210.
   Google Scholar
• Imamura, N., Kusunoki, Y., Kawa-Ha, K., Yumura, K., Hara, J., Oda, K., et al. (1990) "Aggressive natural killer cell leukaemia/ lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells", British Journal of Haematology, 75, 49–59.
   PubMed Web of Science ®Google Scholar
• Kwong, Y.L., Chan, AC., Liang, R., Chiang, AK., Chim, CS., Chan, T.K., et al. (1997) "CD56 + NK lymphomas: clinicopatho-logical features and prognosis", British Journal of Haematology, 97, 821–829.
   PubMed Web of Science ®Google Scholar
• Sun, T., Brody, J., Susin, M., Marino, J., Teichberg, S., Koduru, P., et al. (1993) "Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity", American Journal of Surgery and Pathology, 17, 1289 — 1299.
   PubMed Web of Science ®Google Scholar
• Mateu, R., Badell, I., Alcala, A., Estivill, C., Rubiol, E., Nomdedeu, J., et al. (1998) "Aggressive natural killer cell leukemia: report of a case in a Caucasian boy", Haematologica, 83, 190— 192.
   PubMed Web of Science ®Google Scholar
• Mori, N., Yamashita, Y., Tsuzuki, T., Nakayama, A., Nakazawa, M., Hasegawa, Y., et al. (2000) "Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection", Histopathology, 37, 363— 371.
   Google Scholar
• Siu, L.L., Wong, K.F., Chan, J.K. and Kwong, Y.L. (1999) "Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations", American Journal of Pathology, 155, 1419 — 1425.
   Google Scholar
• Wong, K.F., Zhang, Y.M. and Chan, J.K. (1999) "Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia —is there a consistent pattern?", Leukaemia and Lymphoma, 34, 241–250.
   Google Scholar
• Arase, H., Arase, N. and Saito, T. (1995) "Fas-mediated cytotoxi-city by freshly isolated natural killer cells", Journal of Experimental Medicine, 181, 1235 — 1238.
   Google Scholar
• Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., et al. (1993) "Lethal effect of the anti-Fas antibody in mice", Nature, 364, 806–809.
   PubMed Web of Science ®Google Scholar
• Sato, K., Kimura, F., Nakamura, Y., Murakami, H., Yoshida, M., Tanaka, M., et al. (1996) "An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand", British Journal of Haematology, 94, 379–382.
   Google Scholar
• Gentile, T.C., Uner, A.H., Hutchison, RE., Wright, J., Ben Ezra, J., Russell, E.C., et al. (1994) "CD3 +, CD56 + aggressive variant of large granular lymphocyte leukemia", Blood, 84, 2315–2321.
   PubMed Web of Science ®Google Scholar
• Kanegane, H., Bhatia, K., Gutierrez, M., Kaneda, H., Wada, T., Yachie, A., et al. (1998) "A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma", Blood, 91, 2085–2091.
   Google Scholar
• Quintanilla-Martinez, L., Kumar, S., Fend, F., Reyes, E., Teruya-Feldstein, J., Kingma, D.W., et al. (2000) "Fulminant EBV( + ) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome", Blood, 96, 443 — 451.
   PubMed Web of Science ®Google Scholar
• Tao, Q., Ho, F.C., Loke, S.L. and Srivastava, G. (1995) "Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type", International Journal of Cancer, 3, 315— 320.
   Google Scholar
• Kwong, Y.L., Chan, A.C. and Liang, R.H. (1997) "Natural killer cell lymphoma/leukemia: pathology and treatment", Hematology and Oncology, 15, 71 — 79.
   PubMed Web of Science ®Google Scholar
• Timens, S. CD21., In: Editors. Leucocyte Typing VII, edited by Mason D. et al. (2002) Pp. 766–767. Oxford University Press.
   Google Scholar
• Soler, J., Bordes, R., Ortuno, F., Montagud, M., Martorell, J., Pons, C., et al. (1994) "Aggressive natural killer cell leukaemia/ lymphoma in two patients with lethal midline granuloma", British Journal of Haematology, 86, 659–662.
   Google Scholar
• Quintanilla-Martinez, L. and Jaffe, E.S. (2000) "Commentary: aggressive NK cell lymphomas: insights into the spectrum of NK cell derived malignancies", Histopathology, 37, 372— 374.
   Google Scholar
• Teshima, T., Miyaji, R., Fukuda, M. and Ohshima, K. (1996) "Bone-marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemia", Lancet, 347, 1124.
   Google Scholar
• Mukai, H.Y., Kojima, H., Suzukawa, K., Hon, M., Komeno, T., Hasegawa, Y., et al. (1999) "High-dose chemotherapy with peripheral blood stem cell rescue in blastoid natural killer cell lymphoma", Leukaemia and Lymphoma, 32, 583 — 588.
   Google Scholar
• Anel, A., Buferne, M., Boyer, C., Schmitt-Verhulst, A.M. and Golstein, P. (1994) "T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A", European Journal of Immunology, 24, 2469 — 2476.
   Google Scholar
• Condiotti, R. and Nagler, A. (1996) "Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity", Bone Marrow Transplant, 18, 713–720.
   PubMed Web of Science ®Google Scholar
• McAleer, J.J., O'Loan, D. and Hollywood, D.P. (2001) "Broadcast quality teleconferencing for oncology", Oncologist, 6, 459–462.
   PubMed Web of Science ®Google Scholar